Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2012, Article ID 561494, 15 pages
http://dx.doi.org/10.1155/2012/561494
Review Article

The Role of Cytokines and Inflammatory Cells in Perinatal Brain Injury

Division of Neonatology, Department of Pediatrics, University of Washington, Seattle, WA 98195-6320, USA

Received 15 October 2011; Revised 25 November 2011; Accepted 13 December 2011

Academic Editor: Tara DeSilva

Copyright © 2012 Ryan M. McAdams and Sandra E. Juul. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Outcomes IoMUCoUPBaAH, Preterm Birth: Causes, Consequences, and Prevention, National Academies Press, Washington, DC, USA, 2007.
  2. T. J. Mathews, A. M. Miniño, M. J. K. Osterman, D. M. Strobino, and B. Guyer, “Annual summary of vital statistics: 2008,” Pediatrics, vol. 127, no. 1, pp. 146–157, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. M. C. McCormick, “The contribution of low birth weight to infant mortality and childhood morbidity,” New England Journal of Medicine, vol. 312, no. 2, pp. 82–90, 1985. View at Google Scholar · View at Scopus
  4. B. J. Stoll, N. I. Hansen, E. F. Bell et al., “Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network,” Pediatrics, vol. 126, no. 3, pp. 443–456, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. R. A. Gargus, B. R. Vohr, J. E. Tyson et al., “Unimpaired outcomes for extremely low birth weight infants at 18 to 22 months,” Pediatrics, vol. 124, no. 1, pp. 112–121, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. J. J. Volpe, “Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances,” The Lancet Neurology, vol. 8, no. 1, pp. 110–124, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. H. C. Kinney, “The encephalopathy of prematurity: one pediatric neuropathologist's perspective,” Seminars in Pediatric Neurology, vol. 16, no. 4, pp. 179–190, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. R. L. Haynes, R. D. Folkerth, R. J. Keefe et al., “Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia,” Journal of Neuropathology and Experimental Neurology, vol. 62, no. 5, pp. 441–450, 2003. View at Google Scholar · View at Scopus
  9. A. Foster-Barber, B. Dickens, and D. M. Ferriero, “Human perinatal asphyxia: correlation of neonatal cytokines with MRI and outcome,” Developmental Neuroscience, vol. 23, no. 3, pp. 213–218, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. O. Dammann and T. M. O'Shea, “Cytokines and perinatal brain damage,” Clinics in Perinatology, vol. 35, no. 4, pp. 643–663, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. M. A. Elovitz, A. G. Brown, K. Breen, L. Anton, M. Maubert, and I. Burd, “Intrauterine inflammation, insufficient to induce parturition, still evokes fetal and neonatal brain injury,” International Journal of Developmental Neuroscience, vol. 29, no. 6, pp. 663–671, 2011. View at Publisher · View at Google Scholar · View at PubMed
  12. S. Malaeb and O. Dammann, “Fetal inflammatory response and brain injury in the preterm newborn,” Journal of Child Neurology, vol. 24, no. 9, pp. 1119–1126, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. C. A. Dinarello, “Proinflammatory cytokines,” Chest, vol. 118, no. 2, pp. 503–508, 2000. View at Google Scholar · View at Scopus
  14. V. Tayal and B. S. Kalra, “Cytokines and anti-cytokines as therapeutics - An update,” European Journal of Pharmacology, vol. 579, no. 1–3, pp. 1–12, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. W. Rostène, M.-A. Dansereau, D. Godefroy et al., “Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system,” Journal of Neurochemistry, vol. 118, no. 5, pp. 680–694, 2011. View at Publisher · View at Google Scholar · View at PubMed
  16. M. C. Morganti-Kossman, P. M. Lenzlinger, V. Hans et al., “Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue,” Molecular Psychiatry, vol. 2, no. 2, pp. 133–136, 1997. View at Google Scholar · View at Scopus
  17. G. Sebire, D. Emilie, C. Wallon et al., “In vitro production of IL-6, IL-1β, and tumor necrosis factor-α by human embryonic microglial and neural cells,” Journal of Immunology, vol. 150, no. 4, pp. 1517–1523, 1993. View at Google Scholar · View at Scopus
  18. S. C. Lee, W. Liu, D. W. Dickson, C. F. Brosnan, and J. W. Berman, “Cytokine production by human fetal microglia and astrocytes: differential induction by lipopolysaccharide and IL-1β,” Journal of Immunology, vol. 150, no. 7, pp. 2659–2667, 1993. View at Google Scholar · View at Scopus
  19. W. A. Banks, “Blood-brain barrier transport of cytokines: a mechanism for neuropathology,” Current Pharmaceutical Design, vol. 11, no. 8, pp. 973–984, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. J. L. Wynn and O. Levy, “Role of innate host defenses in susceptibility to early-onset neonatal sepsis,” Clinics in Perinatology, vol. 37, no. 2, pp. 307–337, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. O. Levy, “Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll-like receptor agonists,” Journal of Endotoxin Research, vol. 11, no. 2, pp. 113–116, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. O. Levy, “Innate immunity of the newborn: basic mechanisms and clinical correlates,” Nature Reviews Immunology, vol. 7, no. 5, pp. 379–390, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. O. Levy, M. Coughlin, B. N. Cronstein, R. M. Roy, A. Desai, and M. R. Wessels, “The adenosine system selectively inhibits TLR-mediated TNF-α production in the human newborn,” Journal of Immunology, vol. 177, no. 3, pp. 1956–1966, 2006. View at Google Scholar · View at Scopus
  24. B. Engelhardt and L. Sorokin, “The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction,” Seminars in Immunopathology, vol. 31, no. 4, pp. 497–511, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. N. J. Abbott, L. Rönnbäck, and E. Hansson, “Astrocyte-endothelial interactions at the blood-brain barrier,” Nature Reviews Neuroscience, vol. 7, no. 1, pp. 41–53, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. Z. Redzic, “Molecular biology of the blood-brain and the blood-cerebrospinalfluid barriers: similarities and differences,” Cerebrospinal Fluid Research, vol. 8, article 3, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. M. Khalil, J. Ronda, M. Weintraub, K. Jain, R. Silver, and A. J. Silverman, “Brain mast cell relationship to neurovasculature during development,” Brain Research, vol. 1171, no. 1, pp. 18–29, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. N. R. Saunders, C. J. Ek, M. D. Habgood, and K. M. Dziegielewska, “Barriers in the brain: a renaissance?” Trends in Neurosciences, vol. 31, no. 6, pp. 279–286, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. A. S. Lossinsky and R. R. Shivers, “Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review,” Histology and Histopathology, vol. 19, no. 2, pp. 535–564, 2004. View at Google Scholar · View at Scopus
  30. S. M. Stamatovic, R. F. Keep, and A. V. Andjelkovic, “Brain endothelial cell-cell junctions: how to “open” the blood brain barrier,” Current Neuropharmacology, vol. 6, no. 3, pp. 179–192, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. N. R. Saunders, G. W. Knott, and K. M. Dziegielewska, “Barriers in the immature brain,” Cellular and Molecular Neurobiology, vol. 20, no. 1, pp. 29–40, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. N. R. Saunders, M. D. Habgood, and K. M. Dziegielewska, “Barrier mechanisms in the brain, II. Immature brain,” Clinical and Experimental Pharmacology and Physiology, vol. 26, no. 2, pp. 85–91, 1999. View at Google Scholar · View at Scopus
  33. H. B. Stolp, K. M. Dziegielewska, C. J. Ek et al., “Breakdown of the blood-brain barrier to proteins in white matter of the developing brain following systemic inflammation,” Cell and Tissue Research, vol. 320, no. 3, pp. 369–378, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. C. J. Ek, K. M. Dziegielewska, H. Stolp, and N. R. Saunders, “Functional effectiveness of the blood-brain barrier to small water-soluble molecules in developing and adult opossum (Monodelphis domestica),” Journal of Comparative Neurology, vol. 496, no. 1, pp. 13–26, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. K. M. Dziegielewska, J. Ek, M. D. Habgood, and N. R. Saunders, “Development of the choroid plexus,” Microscopy Research and Technique, vol. 52, no. 1, pp. 5–20, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Hagberg and C. Mallard, “Effect of inflammation on central nervous system development and vulnerability,” Current Opinion in Neurology, vol. 18, no. 2, pp. 117–123, 2005. View at Google Scholar · View at Scopus
  37. O. Dammann and A. Leviton, “Inflammatory brain damage in preterm newborns—dry numbers, wet lab, and causal inferences,” Early Human Development, vol. 79, no. 1, pp. 1–15, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. Y. Pang, Z. Cai, and P. G. Rhodes, “Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide,” Developmental Brain Research, vol. 140, no. 2, pp. 205–214, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Lehnard, C. Lachance, S. Patrizi et al., “The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS,” Journal of Neuroscience, vol. 22, no. 7, pp. 2478–2486, 2002. View at Google Scholar · View at Scopus
  40. K. C. Williams and W. F. Hickey, “Traffic of hematogenous cells through the central nervous system,” Current Topics in Microbiology and Immunology, vol. 202, pp. 221–245, 1995. View at Google Scholar · View at Scopus
  41. P. Megyeri, C. S. Abraham, P. Temesvari, J. Kovacs, T. Vas, and C. P. Speer, “Recombinant human tumor necrosis factor α constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets,” Neuroscience Letters, vol. 148, no. 1-2, pp. 137–140, 1992. View at Publisher · View at Google Scholar · View at Scopus
  42. V. J. Quagliarello, B. Wispelwey, W. J. Long, and W. M. Scheld, “Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat: characterization and comparison with tumor necrosis factor,” Journal of Clinical Investigation, vol. 87, no. 4, pp. 1360–1366, 1991. View at Google Scholar · View at Scopus
  43. P. Zeni, E. Doepker, U. S. Topphoff, S. Huewel, T. Tenenbaum, and H. J. Galla, “MMPs contribute to TNF-α-induced alteration of the blood-cerebrospinal fluid barrier in vitro,” American Journal of Physiology, vol. 293, no. 3, pp. C855–C864, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. H. Xaio, W. A. Banks, M. L. Niehoff, and J. E. Morley, “Effect of LPS on the permeability of the blood-brain barrier to insulin,” Brain Research, vol. 896, no. 1-2, pp. 36–42, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. B. Bauer, A. M. S. Hartz, and D. S. Miller, “Tumor necrosis factor α and endothelin-1 increase p-glycoprotein expression and transport activity at the blood-brain barrier,” Molecular Pharmacology, vol. 71, no. 3, pp. 667–675, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. Z. Fabry, K. M. Fitzsimmons, J. A. Herlein, T. O. Moninger, M. B. Dobbs, and M. N. Hart, “Product ion of the cytokines interleukin 1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes,” Journal of Neuroimmunology, vol. 47, no. 1, pp. 23–34, 1993. View at Publisher · View at Google Scholar · View at Scopus
  47. T. M. Reyes, Z. Fabry, and C. L. Coe, “Brain endothelial cell production of a neuroprotective cytokine, interleukin-6, in response to noxious stimuli,” Brain Research, vol. 851, no. 1-2, pp. 215–220, 1999. View at Publisher · View at Google Scholar · View at Scopus
  48. P. B. Eisenhauer, M. S. Jacewicz, K. J. Conn et al., “Escherichia coli Shiga toxin 1 and TNF-α induce cytokine release by human cerebral microvascular endothelial cells,” Microbial Pathogenesis, vol. 36, no. 4, pp. 189–196, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. S. Verma, R. Nakaoke, S. Dohgu, and W. A. Banks, “Release of cytokines by brain endothelial cells: a polarized response to lipopolysaccharide,” Brain, Behavior, and Immunity, vol. 20, no. 5, pp. 449–455, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. W. Pan, C. Cain, Y. Yu, and A. J. Kastin, “Receptor-mediated transport of LIF across blood-spinal cord barrier is upregulated after spinal cord injury,” Journal of Neuroimmunology, vol. 174, no. 1-2, pp. 119–125, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. R. Koneru, D. Kobiler, S. Lehrer et al., “Macrophages play a key role in early blood brain barrier reformation after hypothermic brain injury,” Neuroscience Letters, vol. 501, no. 3, pp. 148–151, 2011. View at Publisher · View at Google Scholar · View at PubMed
  52. K. Takeda and S. Akira, “Toll-like receptors,” Current Protocols in Immunology, vol. 14, unit 14.12, 2007. View at Google Scholar · View at Scopus
  53. R. Romero, S. Durum, C. A. Dinarello, E. Oyarzun, J. C. Hobbins, and M. D. Mitchell, “Interleukin-1 stimulates prostaglandin biosynthesis by human amnion,” Prostaglandins, vol. 37, no. 1, pp. 13–22, 1989. View at Google Scholar · View at Scopus
  54. M. D. Mitchell, D. J. Dudley, S. S. Edwin, and S. L. Schiller, “Interleukin-6 stimulates prostaglandin production by human amnion and decidual cells,” European Journal of Pharmacology, vol. 192, no. 1, pp. 189–191, 1991. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Taniguchi, N. Matsuzaki, T. Kameda et al., “The enhanced production of placental interleukin-1 during labor and intrauterine infection,” American Journal of Obstetrics and Gynecology, vol. 165, no. 1, pp. 131–137, 1991. View at Google Scholar · View at Scopus
  56. S. L. Hillier, S. S. Witkin, M. A. Krohn, D. H. Watts, N. B. Kiviat, and D. A. Eschenbach, “The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection,” Obstetrics and Gynecology, vol. 81, no. 6, pp. 941–948, 1993. View at Google Scholar · View at Scopus
  57. K. M. Adams Waldorf, C. E. Rubens, and M. G. Gravett, “Use of nonhuman primate models to investigate mechanisms of infection-associated preterm birth,” British Journal of Obstetrics and Gynaecology, vol. 118, no. 2, pp. 136–144, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. R. Romero, D. T. Brody, E. Oyarzun et al., “Infection and labor—III. Interleukin-1: a signal for the onset of parturition,” American Journal of Obstetrics and Gynecology, vol. 160, no. 5, pp. 1117–1123, 1989. View at Google Scholar · View at Scopus
  59. R. Romero, C. Avila, U. Santhanam, and P. B. Sehgal, “Amniotic fluid interleukin 6 in preterm labor. Association with infection,” Journal of Clinical Investigation, vol. 85, no. 5, pp. 1392–1399, 1990. View at Google Scholar · View at Scopus
  60. R. Romero, M. Ceska, C. Avila, M. Mazor, E. Behnke, and I. Lindley, “Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition,” American Journal of Obstetrics and Gynecology, vol. 165, no. 4 I, pp. 813–820, 1991. View at Google Scholar · View at Scopus
  61. R. Romero, K. R. Manogue, M. D. Mitchell et al., “Infection and labor—IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor,” American Journal of Obstetrics and Gynecology, vol. 161, no. 2, pp. 336–341, 1989. View at Google Scholar · View at Scopus
  62. H. J. Kadhim, J. Duchateau, and G. Sébire, “Cytokines and brain injury: invited review,” Journal of Intensive Care Medicine, vol. 23, no. 4, pp. 236–249, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. E. Molina-Holgado and F. Molina-Holgado, “Mending the broken brain: neuroimmune interactions in neurogenesis,” Journal of Neurochemistry, vol. 114, no. 5, pp. 1277–1290, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. S. L. Bailey, P. A. Carpentier, E. J. McMahon, W. S. Begolka, and S. D. Miller, “Innate and adaptive immune responses of the central nervous system,” Critical Reviews in Immunology, vol. 26, no. 2, pp. 149–188, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. J. M. Vela, E. Molina-Holgado, Á. Arévalo-Martín, G. Almazán, and C. Guaza, “Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells,” Molecular and Cellular Neuroscience, vol. 20, no. 3, pp. 489–502, 2002. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Aschner, “Immune and inflammatory responses in the CNS: modulation by astrocytes,” Toxicology Letters, vol. 102-103, pp. 283–287, 1998. View at Publisher · View at Google Scholar · View at Scopus
  67. H. Kadhim, B. Tabarki, G. Verellen, C. De Prez, A. M. Rona, and G. Sébire, “Inflammatory cytokines in the pathogenesis of periventricular leukomalacia,” Neurology, vol. 56, no. 10, pp. 1278–1284, 2001. View at Google Scholar · View at Scopus
  68. H. Hagberg, E. Gilland, E. Bona et al., “Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats,” Pediatric Research, vol. 40, no. 4, pp. 603–609, 1996. View at Google Scholar · View at Scopus
  69. V. Wee Yong, “Inflammation in neurological disorders: a help or a hindrance?” Neuroscientist, vol. 16, no. 4, pp. 408–420, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. G. Favrais, Y. Van De Looij, B. Fleiss et al., “Systemic inflammation disrupts the developmental program of white matter,” Annals of Neurology, vol. 70, no. 4, pp. 550–565, 2011. View at Publisher · View at Google Scholar · View at PubMed
  71. J. V. Welser-Alves, S. J. Crocker, and R. Milner, “A dual role for microglia in promoting tissue inhibitor of metalloproteinase (TIMP) expression in glial cells in response to neuroinflammatory stimuli,” Journal of Neuroinflammation, vol. 8, article 61, 2011. View at Publisher · View at Google Scholar · View at PubMed
  72. A. Ould-Yahoui, E. Tremblay, O. Sbai et al., “A new role for TIMP-1 in modulating neurite outgrowth and morphology of cortical neurons,” PLoS ONE, vol. 4, no. 12, Article ID e8289, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. C. S. Moore, R. Milner, A. Nishiyama et al., “Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination,” Journal of Neuroscience, vol. 31, no. 16, pp. 6247–6254, 2011. View at Publisher · View at Google Scholar · View at PubMed
  74. P. Svedin, H. Hagberg, K. Sävman, C. Zhu, and C. Mallard, “Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia,” Journal of Neuroscience, vol. 27, no. 7, pp. 1511–1518, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. R. L. Goldenberg, J. C. Hauth, and W. W. Andrews, “Intrauterine infection and preterm delivery,” New England Journal of Medicine, vol. 342, no. 20, pp. 1500–1507, 2000. View at Publisher · View at Google Scholar · View at Scopus
  76. Y. W. Wu and J. M. Colford, “Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis,” Journal of the American Medical Association, vol. 284, no. 11, pp. 1417–1424, 2000. View at Google Scholar · View at Scopus
  77. J. G. Shatrov, S. C. M. Birch, L. T. Lam, J. A. Quinlivan, S. McIntyre, and G. L. Mendz, “Chorioamnionitis and cerebral palsy: a meta-analysis,” Obstetrics and Gynecology, vol. 116, no. 2, pp. 387–392, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. V. M. Abrahams, P. Bole-Aldo, Y. M. Kim et al., “Divergent trophoblast responses to bacterial products mediated by TLRs,” Journal of Immunology, vol. 173, no. 7, pp. 4286–4296, 2004. View at Google Scholar · View at Scopus
  79. C. Mallard and H. Hagberg, “Inflammation-induced preconditioning in the immature brain,” Seminars in Fetal and Neonatal Medicine, vol. 12, no. 4, pp. 280–286, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. B. H. Yoon, R. Romero, S. H. Yang, J. K. Jun, I. O. Kim, and J. H. Choi, “Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia,” American Journal of Obstetrics and Gynecology, vol. 174, no. 5, pp. 1433–1440, 1996. View at Publisher · View at Google Scholar · View at Scopus
  81. O. Dammann and A. Leviton, “Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant,” Seminars in Pediatric Neurology, vol. 5, no. 3, pp. 190–201, 1998. View at Publisher · View at Google Scholar · View at Scopus
  82. G. Oggé, R. Romero, D.-C. Lee et al., “Chronic chorioamnionitis displays distinct alterations of the amniotic fluid proteome,” Journal of Pathology, vol. 223, no. 4, pp. 553–565, 2011. View at Publisher · View at Google Scholar · View at PubMed
  83. H. Martin, B. Olander, and M. Norman, “Reactive hyperemia and interleukin 6, interleukin 8, and tumor necrosis factor-alpha in the diagnosis of early-onset neonatal sepsis,” Pediatrics, vol. 108, no. 4, article E61, 2001. View at Google Scholar · View at Scopus
  84. P. C. Ng, K. Li, K. M. Chui et al., “IP-10 is an early diagnostic marker for identification of late-onset bacterial infection in preterm infants,” Pediatric Research, vol. 61, no. 1, pp. 93–98, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  85. S. R. Hintz, D. E. Kendrick, B. J. Stoll et al., “Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis,” Pediatrics, vol. 115, no. 3, pp. 696–703, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  86. R. S. Procianoy and R. C. Silveira, “Association between high cytokine levels with white matter injury in preterm infants with sepsis,” Pediatric Critical Care Medicine. In press.
  87. C. P. Speer, “Pulmonary inflammation and bronchopulmonary dysplasia,” Journal of Perinatology, vol. 26, no. 1, supplement, pp. S57–S62, 2006. View at Publisher · View at Google Scholar · View at PubMed
  88. L. Gagliardi, R. Bellù, R. Zanini, and O. Dammann, “Bronchopulmonary dysplasia and brain white matter damage in the preterm infant: a complex relationship,” Paediatric and Perinatal Epidemiology, vol. 23, no. 6, pp. 582–590, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  89. L. A. Koman, B. P. Smith, and J. S. Shilt, “Cerebral palsy,” Lancet, vol. 363, no. 9421, pp. 1619–1631, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  90. R. M. McAdams and S. E. Juul, “Cerebral palsy: prevalence, predictability, and parental counseling,” NeoReviews, vol. 12, no. 10, pp. e564–e574, 2011. View at Publisher · View at Google Scholar
  91. S. A. Back, N. L. Luo, R. A. Mallinson et al., “Selective vulnerability of preterm white matter to oxidative damage defined by F2-isoprostanes,” Annals of Neurology, vol. 58, no. 1, pp. 108–120, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  92. W. Deng, J. Pleasure, and D. Pleasure, “Progress in periventricular leukomalacia,” Archives of Neurology, vol. 65, no. 10, pp. 1291–1295, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  93. L. M. Nagae, A. H. Hoon, E. Stashinko et al., “Diffusion tensor imaging in children with periventricular leukomalacia: variability of injuries to white matter tracts,” American Journal of Neuroradiology, vol. 28, no. 7, pp. 1213–1222, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. V. J. Ellison, T. J. Mocatta, C. C. Winterbourn, B. A. Darlow, J. J. Volpe, and T. E. Inder, “The relationship of CSF and plasma cytokine levels to cerebral white matter injury in the premature newborn,” Pediatric Research, vol. 57, no. 2, pp. 282–286, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  95. H. C. Huang, C. L. Wang, L. T. Huang et al., “Association of cord blood cytokines with prematurity and cerebral palsy,” Early Human Development, vol. 77, no. 1-2, pp. 29–36, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  96. W. A. Carlo, S. A. McDonald, J. E. Tyson et al., “Cytokines and neurodevelopmental outcomes in extremely low birth weight infants,” Journal of Pediatrics, vol. 159, no. 6, pp. 919–925, 2011. View at Publisher · View at Google Scholar · View at PubMed
  97. B. H. Yoon, C. W. Park, and T. Chaiworapongsa, “Intrauterine infection and the development of cerebral palsy,” British Journal of Obstetrics and Gynaecology, vol. 110, no. 20, pp. 124–127, 2003. View at Publisher · View at Google Scholar · View at Scopus
  98. S. Lehnardt, “Innate immunity and neuroinflammation in the CNS: the role of microglia in toll-like receptor-mediated neuronal injury,” Glia, vol. 58, no. 3, pp. 253–263, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  99. W. Deng, “Neurobiology of injury to the developing brain,” Nature Reviews Neurology, vol. 6, no. 6, pp. 328–336, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  100. Y. Pang, L. Campbell, B. Zheng, L. Fan, Z. Cai, and P. Rhodes, “Lipopolysaccharide-activated microglia induce death of oligodendrocyte progenitor cells and impede their development.,” Neuroscience, vol. 166, no. 2, pp. 464–475, 2010. View at Google Scholar · View at Scopus
  101. C. Y. Lin, Y. C. Chang, S. T. Wang, T. Y. Lee, C. F. Lin, and C. C. Huang, “Altered inflammatory responses in preterm children with cerebral palsy,” Annals of Neurology, vol. 68, no. 2, pp. 204–212, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  102. L. F. Shalak and J. M. Perlman, “Infection markers and early signs of neonatal encephalopathy in the term infant,” Mental Retardation and Developmental Disabilities Research Reviews, vol. 8, no. 1, pp. 14–19, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  103. L. F. Shalak, A. R. Laptook, H. S. Jafri, O. Ramilo, and J. M. Perlman, “Clinical chorioamnionitis, elevated cytokines, and brain injury in term infants,” Pediatrics, vol. 110, no. 4, pp. 673–680, 2002. View at Publisher · View at Google Scholar · View at Scopus
  104. K. B. Nelson, J. K. Grether, J. M. Dambrosia et al., “Neonatal cytokines and cerebral palsy in very preterm infants,” Pediatric Research, vol. 53, no. 4, pp. 600–607, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  105. Y. W. Wu, G. J. Escobar, J. K. Grether, L. A. Croen, J. D. Greene, and T. B. Newman, “Chorioamnionitis and Cerebral Palsy in Term and Near-Term Infants,” Journal of the American Medical Association, vol. 290, no. 20, pp. 2677–2684, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  106. B. Jacobsson and G. Hagberg, “Antenatal risk factors for cerebral palsy,” Best Practice and Research, vol. 18, no. 3, pp. 425–436, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  107. J. J. Volpe, “Cerebral white matter injury of the premature infant—more common than you think,” Pediatrics, vol. 112, no. 1 I, pp. 176–180, 2003. View at Publisher · View at Google Scholar · View at Scopus
  108. A. I. Bartha, A. Foster-Barber, S. P. Miller et al., “Neonatal encephalopathy: association of cytokines with MR spectroscopy and outcome,” Pediatric Research, vol. 56, no. 6, pp. 960–966, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  109. K. Sävman, M. Blennow, K. Gustafson, E. Tarkowski, and H. Hagberg, “Cytokine response in cerebrospinal fluid after birth asphyxia,” Pediatric Research, vol. 43, no. 6, pp. 746–751, 1998. View at Google Scholar · View at Scopus
  110. B. H. Yoon, R. Romero, J. S. Park et al., “The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis,” American Journal of Obstetrics and Gynecology, vol. 183, no. 5, pp. 1124–1129, 2000. View at Publisher · View at Google Scholar · View at PubMed
  111. A. Leviton, N. Paneth, M. L. Reuss et al., “Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants,” Pediatric Research, vol. 46, no. 5, pp. 566–575, 1999. View at Google Scholar
  112. B. H. Yoon, R. Romero, J. S. Park et al., “Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years,” American Journal of Obstetrics and Gynecology, vol. 182, no. 3, pp. 675–681, 2000. View at Google Scholar
  113. J. Correale and A. Villa, “The neuroprotective role of inflammation in nervous system Injuries,” Journal of Neurology, vol. 251, no. 11, pp. 1304–1316, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  114. M. Djukic, C. S. Gibson, A. H. Maclennan et al., “Genetic susceptibility to viral exposure may increase the risk of cerebral palsy,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 49, no. 3, pp. 247–253, 2009. View at Publisher · View at Google Scholar · View at PubMed
  115. D. Wu, Y.-F. Zou, X.-Y. Xu et al., “The association of genetic polymorphisms with cerebral palsy: a meta-analysis,” Developmental Medicine and Child Neurology, vol. 53, no. 3, pp. 217–225, 2011. View at Publisher · View at Google Scholar · View at PubMed
  116. Y. W. Wu, L. A. Croen, A. R. Torres, J. Van De Water, J. K. Grether, and N. N. Hsu, “Interleukin-6 genotype and risk for cerebral palsy in term and near-term infants,” Annals of Neurology, vol. 66, no. 5, pp. 663–670, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  117. M. Dördelmann, J. Kerk, F. Dressler et al., “Interleukin-10 high producer allele and ultrasound-defined periventricular white matter abnormalities in preterm infants: a preliminary study,” Neuropediatrics, vol. 37, no. 3, pp. 130–136, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  118. S. Thayyil, M. Chandrasekaran, A. Taylor et al., “Cerebral magnetic resonance biomarkers in neonatal encephalopathy: a meta-analysis,” Pediatrics, vol. 125, no. 2, pp. e382–e395, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  119. A. Leviton, K. Kuban, T. M. O'Shea et al., “The relationship between early concentrations of 25 blood proteins and cerebral white matter injury in preterm newborns: the ELGAN study,” Journal of Pediatrics, vol. 158, no. 6, pp. 897.e5–903.e5, 2011. View at Publisher · View at Google Scholar · View at PubMed
  120. S. Shahrara, C. C. Park, V. Temkin, J. W. Jarvis, M. V. Volin, and R. M. Pope, “RANTES modulates TLR4-induced cytokine secretion in human peripheral blood monocytes,” Journal of Immunology, vol. 177, no. 8, pp. 5077–5087, 2006. View at Google Scholar · View at Scopus
  121. M. Digicaylioglu and S. A. Lipton, “Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades,” Nature, vol. 412, no. 6847, pp. 641–647, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  122. N. Byts, A. Samoylenko, T. Fasshauer et al., “Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin,” Cell Death and Differentiation, vol. 15, no. 4, pp. 783–792, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  123. L. Wang, M. Chopp, S. R. Gregg et al., “Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF,” Journal of Cerebral Blood Flow and Metabolism, vol. 28, no. 7, pp. 1361–1368, 2008. View at Publisher · View at Google Scholar · View at PubMed
  124. B. Viviani, S. Bartesaghi, E. Corsini et al., “Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor,” Journal of Neurochemistry, vol. 93, no. 2, pp. 412–421, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  125. E. Spandou, Z. Papadopoulou, V. Soubasi et al., “Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats,” Brain Research, vol. 1045, no. 1-2, pp. 22–30, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  126. S. Rees, N. Hale, R. De Matteo et al., “Erythropoietin is neuroprotective in a preterm ovine model of endotoxin-induced brain injury,” Journal of Neuropathology and Experimental Neurology, vol. 69, no. 3, pp. 306–319, 2010. View at Publisher · View at Google Scholar · View at PubMed
  127. E. J. Demers, R. J. McPherson, and S. E. Juul, “Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia,” Pediatric Research, vol. 58, no. 2, pp. 297–301, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  128. B. A. Kellert, R. J. McPherson, and S. E. Juul, “A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats,” Pediatric Research, vol. 61, no. 4, pp. 451–455, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  129. F. F. Gonzalez, R. Abel, C. R. Almli, D. Mu, M. Wendland, and D. M. Ferriero, “Erythropoietin sustains cognitive function and brain volume after neonatal stroke,” Developmental Neuroscience, vol. 31, no. 5, pp. 403–411, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  130. M. Yamada, C. Burke, P. Colditz, D. W. Johnson, and G. C. Gobe, “Erythropoietin protects against apoptosis and increases expression of non-neuronal cell markers in the hypoxia-injured developing brain,” Journal of Pathology, vol. 224, no. 1, pp. 101–109, 2011. View at Publisher · View at Google Scholar · View at PubMed
  131. S. Genc, K. Genc, A. Kumral, and H. Ozkan, “White matter protection by erythropoietin: an emerging matter in the treatment of neonatal hypoxic-ischemic brain injury,” Stroke, vol. 41, no. 11, article e595, 2010. View at Publisher · View at Google Scholar · View at PubMed
  132. Y. Sun, J. W. Calvert, and J. H. Zhang, “Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration,” Stroke, vol. 36, no. 8, pp. 1672–1678, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  133. S. E. Juul, R. P. Beyer, T. K. Bammler, R. J. Mcpherson, J. Wilkerson, and F. M. Farin, “Microarray analysis of high-dose recombinant erythropoietin treatment of unilateral brain injury in neonatal mouse hippocampus,” Pediatric Research, vol. 65, no. 5, pp. 485–492, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  134. M. Iwai, G. Cao, W. Yin, R. A. Stetler, J. Liu, and J. Chen, “Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats,” Stroke, vol. 38, no. 10, pp. 2795–2803, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  135. F. F. Gonzalez, P. McQuillen, D. Mu et al., “Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke,” Developmental Neuroscience, vol. 29, no. 4-5, pp. 321–330, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  136. M. Iwai, R. A. Stetler, J. Xing et al., “Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury,” Stroke, vol. 41, no. 5, pp. 1032–1037, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  137. S. E. Juul, R. J. McPherson, L. A. Bauer, K. J. Ledbetter, C. A. Gleason, and D. E. Mayock, “A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety,” Pediatrics, vol. 122, no. 2, pp. 383–391, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  138. J. C. Fauchère, C. Dame, R. Vonthein et al., “An approach to using recombinant erythropoietin for neuroprotection in very preterm infants,” Pediatrics, vol. 122, no. 2, pp. 375–382, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  139. R. Hardeland, “Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance,” Endocrine, vol. 27, no. 2, pp. 119–130, 2005. View at Publisher · View at Google Scholar · View at Scopus
  140. J. C. Mayo, R. M. Sainz, D. X. Tan et al., “Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages,” Journal of Neuroimmunology, vol. 165, no. 1-2, pp. 139–149, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  141. F. Luchetti, B. Canonico, M. Betti et al., “Melatonin signaling and cell protection function,” FASEB Journal, vol. 24, no. 10, pp. 3603–3624, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  142. L. C. Hutton, M. Abbass, H. Dickinson, Z. Ireland, and D. W. Walker, “Neuroprotective properties of melatonin in a model of birth asphyxia in the spiny mouse (Acomys cahirinus),” Developmental Neuroscience, vol. 31, no. 5, pp. 437–451, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  143. A. K. Welin, P. Svedin, R. Lapatto et al., “Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion,” Pediatric Research, vol. 61, no. 2, pp. 153–158, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  144. H. Wang, D. X. Xu, J. W. Lv, H. Ning, and W. Wei, “Melatonin attenuates lipopolysaccharide (LPS)-induced apoptotic liver damage in d-galactosamine-sensitized mice,” Toxicology, vol. 237, no. 1-3, pp. 49–57, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  145. F. Fulia, E. Gitto, S. Cuzzocrea et al., “Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin,” Journal of Pineal Research, vol. 31, no. 4, pp. 343–349, 2001. View at Publisher · View at Google Scholar · View at Scopus
  146. E. Gitto, M. Karbownik, R. J. Reiter et al., “Effects of melatonin treatment in septic newborns,” Pediatric Research, vol. 50, no. 6, pp. 756–760, 2001. View at Google Scholar · View at Scopus
  147. A. Murakami and H. Ohigashi, “Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals,” International Journal of Cancer, vol. 121, no. 11, pp. 2357–2363, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  148. Y. J. Surh, K. S. Chun, H. H. Cha et al., “Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation,” Mutation Research, vol. 480-481, pp. 243–268, 2001. View at Google Scholar · View at Scopus
  149. L. F. He, H. J. Chen, L. H. Qian, G. Y. Chen, and J. S. Buzby, “Curcumin protects pre-oligodendrocytes from activated microglia in vitro and in vivo,” Brain Research, vol. 1339, no. C, pp. 60–69, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  150. E. C. A. Kaal and C. J. Vecht, “The management of brain edema in brain tumors,” Current Opinion in Oncology, vol. 16, no. 6, pp. 593–600, 2004. View at Publisher · View at Google Scholar · View at Scopus
  151. P. K. Stys and S. A. Lipton, “White matter NMDA receptors: an unexpected new therapeutic target?” Trends in Pharmacological Sciences, vol. 28, no. 11, pp. 561–566, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  152. Z. G. Xiong, X. M. Zhu, X. P. Chu et al., “Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels,” Cell, vol. 118, no. 6, pp. 687–698, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  153. A. D. Edwards, P. Brocklehurst, A. J. Gunn et al., “Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data,” British Medical Journal, vol. 340, article c363, 2010. View at Publisher · View at Google Scholar · View at Scopus
  154. B. Mesplès, R. H. Fontaine, V. Lelièvre, J.-M. Launay, and P. Gressens, “Neuronal TGF-β1 mediates IL-9/mast cell interaction and exacerbates excitotoxicity in newborn mice,” Neurobiology of Disease, vol. 18, no. 1, pp. 193–205, 2005. View at Publisher · View at Google Scholar · View at PubMed
  155. Y. Jin, A. J. Silverman, and S. J. Vannucci, “Mast cell stabilization limits hypoxic-ischemic brain damage in the immature rat,” Developmental Neuroscience, vol. 29, no. 4-5, pp. 373–384, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus